企业摘要
季度业绩走势
营业收入
营业利润率
市场偏好度
※ 点击图表可查看该月份的AI分析信息。
营业收入
合并
单独
营业利润
合并
单独
净利润
合并
单独
财务信息
保存为Excel
该期间没有财务信息数据。
~
季度
决算
*单位基准小数点第四位以下的数值标记为'0/-0'
财务指标预测
※ 本预测值是基于历史数据的AI简单估算值，可能与实际业绩存在差异。
企业概况
截至2026年6月
KOREA PHARMA Co., Ltd. has strengths in manufacturing neuropsychiatric, digestive, circulatory, and antibacterial/antibiotic drugs through its own R&D, and manufactures and sells other prescription drugs for various disease groups, including endocrine, respiratory, anti-inflammatory, and diabetes drugs. In July 2018, the company opened its New Drug Research Center at the Daegu Advanced Medical Complex, which plans to expand its skilled workforce going forward to conduct specialized research in biologic new drugs, improved new drugs based on DDS (Drug Delivery System), and contrast media, as well as various national research projects. In addition, as of June 14, 2021, its existing Hyangnam Central Research Institute expanded and relocated to the Uiwang Knowledge Industry Center, improving transportation, geographic conditions, and the research environment; this is expected to help the company more systematically recruit talented personnel and advance new drugs and improved new drugs that will become the company's future growth drivers, and is expected to further accelerate the development speed of its currently secured new drug candidates.
代表理事
Park Eunhui
成立日期
1985年12月24日
法人类型
韩国创业板
行业分类
Manufacture of medicaments
法人注册号
18011-0059112
营业执照号
124-81-15899
电话号码
02-2162-8416
传真号码
02-558-1677
公司地址
87 Jeyakgongdan 3-gil, Hyangnam-eup, Manse-gu, Hwaseong-si, Gyeonggi-do
产品与服务
评论